Salesforce (Salesforce (CRM)) reported its first-quarter results on Wednesday, and the reaction from Wall Street can best be summed up as: "Eh, it's fine." Not terrible, not great — just fine. And for a stock that's already down more than 30% this year, "fine" isn't exactly what bulls were hoping for.

Analysts mostly maintained their ratings, though several trimmed price targets. The big question hanging over Salesforce is whether its AI push — specifically the Agentforce platform — can reignite growth, or whether the company is just another legacy software vendor struggling to prove it has a real AI story.

The Analyst Rundown

Here's what the Street had to say:

DA Davidson (Gil Luria): Neutral rating, price target cut from $200 to $175. Luria noted that expectations were low, but results and guidance still disappointed bulls. He called Agentforce momentum "an area of strength" and described the quarter as a "solid start to the year," but said updated guidance keeps growth expectations in check.

BofA Securities (Tal Liani): Underperform, $160 target. Liani called the results "uninspiring" and said "trends remain underwhelming." His focus is on decelerating revenue, muted growth, and rising competitive risks.

KeyBanc (Jackson Ader): Overweight, target lowered from $300 to $290. Ader said Q1 was "just fine" and highlighted impressive AI metrics and usage statistics. He expects more Agentforce growth in the second half.

Guggenheim (John DiFucci): Neutral, no price target. DiFucci said Q1 did "nothing to dispel the AI threat narrative" and called management's expectations for accelerated second-half growth "tough." He added, "We continue to believe that CRM, like many application companies, still has little to show for in terms of material incremental AI revenue as reflected in its overall growth rates."

Citizens (Patrick Walravens): Market Outperform, $315 target. Walravens highlighted Agentforce hitting a $1.2 billion annual run rate as a key positive. He acknowledged mixed guidance may have hurt investor sentiment but listed several reasons to like the story: Agentforce growth, strong customer usage, solid margins, second-half expectations, a $50 billion buyback, and the management team.

Wedbush (Dan Ives): Outperform, $325 target. Ives called Agentforce results "solid" and said the company is on track to accelerate organic growth in the second half. He anticipates "a growth inflection in FY27 on the back of Agentforce and Data Cloud" and noted a strong pipeline for Agentforce.

Cantor Fitzgerald (Matthew VanVliet): Overweight, $250 target. VanVliet said Q1 was a non-event unlikely to change investor opinions. He noted that without meaningful bookings or cRPO beats, investors are left "having to trust management that the F2H acceleration is around the corner." He warned the stock could face pressure until the next quarterly report.

The Agentforce Bright Spot

Across the board, Agentforce was the one thing analysts could agree on. The AI agent platform hit a $1.2 billion annual run rate, and management talked up strong usage and a robust pipeline. For a company that's been under pressure to show it can monetize AI, that's a meaningful data point.

But the question remains: Is Agentforce enough to offset broader headwinds? Revenue growth is decelerating, competition is intensifying, and the stock is trading near its 52-week low of $163.52. At $179.75, it's down 32% year-to-date.

Several analysts are betting on a second-half rebound, but as DiFucci pointed out, that narrative requires a leap of faith. Investors will be watching the next quarter closely for signs that the acceleration is real.

For now, Salesforce is a story of two halves: a legacy business that's struggling to impress, and an AI bet that's showing promise but hasn't yet moved the needle on overall growth. The market seems to be saying, "Show me."